Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Oxford BioMedica
Life Sciences
Gene-therapy for Parkinson’s: clinical progression
14 Jun 2018
Evgen Pharma
Life Sciences
Encouraging interim data from the STEM trial
By
Dr Martin Hall
13 Jun 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Incanthera Ltd
Life Sciences
Pre-IPO research – targeting the warheads
By
Dr Martin Hall
12 Jun 2018
Bionomics Ltd
Life Sciences
A big deal in oncology?
By
Dr Martin Hall
04 Jun 2018
Avacta Group plc
Life Sciences
In vivo expression of Affimers
By
Dr Martin Hall
31 May 2018
Bionomics Ltd
Life Sciences
Third Phase II trial of BNC210 begins
By
Dr Martin Hall
30 May 2018
Allergy Therapeutics plc
Life Sciences
Opening the door to registration
By
Dr Martin Hall
21 May 2018
Redx Pharma
Life Sciences
Clinical and corporate update
By
Dr Martin Hall
15 May 2018
Alliance Pharma Plc
Life Sciences
Entering the US market
By
Dr Martin Hall
19 Apr 2018
Avacta Group plc
Life Sciences
Commendable rate of progress
By
Dr Martin Hall
17 Apr 2018
genedrive Plc
Life Sciences
Progressing commercialisation plans
By
Dr Martin Hall
12 Apr 2018
Prev
1
...
13
14
15
16
17
...
22
Next
